EKF Diagnostics Holdings (EKF)

Sector:

Financials

Index:

FTSE AIM All-Share

28.00p
   
  • Change Today:
      0.40p
  • 52 Week High: 31.90
  • 52 Week Low: 18.75
  • Currency: UK Pounds
  • Shares Issued: 446.44m
  • Volume: 28,359
  • Market Cap: £125.00m
  • Beta: 0.26

EKF Overview

EKF Diagnostics is a global medical manufacturer of point-of-care and central lab devices and chemistry reagents including hemoglobin tests, HbA1c tests, glucose and lactate tests.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 12.5% 15.4%
ROCE 8.6%  
Latest F'cast
P/E 20.3 19.6
PEG 0.1 10.3
Pr/Revenue 2.5 2.3
Pr/Book 1.7  
Latest F'cast
Revenue -4.6% 4.8%
PBT 193.9% 29.5%
EPS 165.4% 1.9%
DPS n/a n/a

EKF Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 65.26 15.36 2.45p 29.3 0.1 +202% 1.10p 1.5%
31-Dec-21 81.84 21.43 3.47p 21.6 0.5 +42% 1.20p 1.6%
31-Dec-22 66.64 (8.94) (2.21)p n/a n/a n/a 1.20p 2.4%
31-Dec-23 52.61 2.13 0.52p 60.9 n/a n/a n/a 0.0%
31-Dec-24 50.19 6.26 1.38p 19.6 0.1 +165% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

EKF Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 52.62 8.11 1.41p 19.9 10.4 +2% n/a 0.0%
31-Dec-26 57.29 9.63 1.71p 16.4 0.8 +21% n/a 0.0%
31-Dec-27 61.62 10.78 1.92p 14.6 1.2 +13% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

EKF Company Announcements

Share Buyback & Extension of Buyback Programme 21-Oct-2025 15:10 RNS
Share Buyback (Replacement) 20-Oct-2025 12:24 RNS
Share Buyback 20-Oct-2025 11:36 RNS

Latest EKF Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

EKF Market Data

Currency UK Pounds
Share Price 28.00p
Change Today 0.40p
% Change 1.45 %
52 Week High 31.90
52 Week Low 18.75
Volume 28,359
Shares Issued 446.44m
Market Cap £125.00m
Beta 0.26

EKF Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.32% below the market average90.32% below the market average90.32% below the market average90.32% below the market average90.32% below the market average
89.8% below the sector average89.8% below the sector average89.8% below the sector average89.8% below the sector average89.8% below the sector average
Price Trend
12.36% above the market average12.36% above the market average12.36% above the market average12.36% above the market average12.36% above the market average
28.71% below the sector average28.71% below the sector average28.71% below the sector average28.71% below the sector average28.71% below the sector average
Income Not Available
Growth
61.17% above the market average61.17% above the market average61.17% above the market average61.17% above the market average61.17% above the market average
59.14% above the sector average59.14% above the sector average59.14% above the sector average59.14% above the sector average59.14% above the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

EKF Dividends

  Latest Previous
  Final Final
Ex-Div 02-Nov-23 03-Nov-22
Paid 01-Dec-23 01-Dec-22
Amount 1.20p 1.20p

Trades for 21-Oct-2025

Time Volume / Share Price
15:11 1 @ 27.90p
15:10 2 @ 28.00p
15:10 574 @ 27.90p
15:10 4 @ 27.90p
15:05 32 @ 28.00p

EKF Key Personnel

CFO Stephen (Steve) Young
CEO Gavin T Jones

Top of Page